Integrative multiplatform molecular profiling of benign prostatic hyperplasia identifies distinct subtypes

Journal: Nature Communications

Published: 2020-04-24

DOI: 10.1038/s41467-020-15913-6

Affiliations: 12

Authors: 24

Go to article
Institutions Share
Department of Urology, Cornell University, United States of America (USA) 0.34
Caryl and Israel Englander Institute for Precision Medicine (IPM), Cornell University, United States of America (USA) 0.15
Department of Pathology and Laboratory Medicine, Cornell University, United States of America (USA) 0.09
Beth Israel Deaconess Medical Center (BIDMC), United States of America (USA) 0.08
Centre for Integrative Biology (CIBIO), UNITN, Italy 0.08
Sandra and Edward Meyer Cancer Center, Cornell University, United States of America (USA) 0.06
The HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine (ICB), Cornell University, United States of America (USA) 0.06
Department of Radiology, Cornell University, United States of America (USA) 0.04
Joan and Sanford I. Weill Department of Medicine, Cornell University, United States of America (USA) 0.04
Department of Urology, MGH, United States of America (USA) 0.04
Department for BioMedical Research (DBMR), UniBE, Switzerland 0.01
Bern University Hospital, Switzerland 0.01

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER